Market

October 1, U.S. stocks opened broadly higher as easing Treasury yields and upbeat corporate outlooks lifted risk appetite: the Dow Jones added 0.15%, the S&P 500 climbed 0.17% and the Nasdaq Composite advanced 0.37%.

Accenture PLC soars 19.5% after boosting full-year guidance; IBM climbs 4.6% on record cloud revenue; ServiceNow rallies 3.9% as subscription growth accelerates; Rocket Lab USA, Inc. rises 2.8% on a new NASA launch contract; Alphabet gains 2.1% on fresh AI ad tools; Microsoft adds 1.2% on an analyst upgrade; Nvidia edges up 0.2% ahead of its GTC keynote; Corteva, Inc. plunges 82.0% after a surprise profit warning.

Elsewhere, Universe Pharmaceuticals Inc. jumps 3.7%, United Microelectronics gains 1.6%, Vipshop rises 1.3%, Alibaba adds 1.2%, JD.com ticks up 0.7% and XPeng Inc. advances 0.9% as sentiment improves toward China ADRs and EV names.

News

Accenture lifts fiscal-year outlook, stock spikes 19.5%. The consulting giant reported stronger-than-expected earnings and raised revenue guidance on resilient enterprise tech spending.

IBM unveils new Watsonx AI platform, shares rally 4.6%. Management said the launch will accelerate adoption of generative AI services, boosting high-margin software growth.

Corteva issues sharp profit warning, shares collapse 82%. The seed and crop-protection firm cited weak commodity prices and rising costs, slashing its second-half earnings forecast.

ServiceNow beats on subscription surge, up 3.9%. Record annual recurring revenue and stronger billings prompted the company to increase its full-year targets.

Alphabet rolls out AI-driven ad tools, stock up 2.1%. New generative features aim to automate creative development and improve campaign performance for advertisers.

Rocket Lab wins multi-launch NASA contract, jumps 2.8%. The agreement for up to five Photon missions bolsters the company’s revenue pipeline through 2029.

Microsoft upgraded by major broker, rises 1.2%. Analysts highlighted accelerating Azure growth and expanding AI monetization opportunities.

Universe Pharmaceuticals soars 3.7% on FDA trial clearance. The agency approved an investigational new drug application for the company’s herbal arthritis treatment.

United Microelectronics boosts U.S. capex plan, ADRs gain 1.6%. The chip foundry will expand advanced-node capacity to meet rising AI semiconductor demand.

Vipshop announces $1 billion buyback, shares add 1.3%. The discount e-commerce firm said the program underscores confidence in its long-term growth and cash flow strength.